Taral Patel, DO
Anesthesiology · Parsippany, NJNPI 1750743472
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,490 of the $8,643 with a category attached, or 63.5%. Pharmacosmos Therapeutics Inc. accounts for 66.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $6,499 and has fallen 88.0% since, to $782 in 2025. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $51.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacosmos Therapeutics Inc.$6K
- AbbVie$973
- Takeda Pharmaceuticals U.S.A., Inc.$501
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$351
- Lilly USA, LLC$177
- QOL Medical, LLC$143
- plus $780 from 17 others
What the payments were for
- Consulting fees$220%
- Speaking & faculty fees$5,49064%
- Travel & lodging$2052%
- Food & beverage$2,92634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 3 | $5,717 |
| AbbVie | 61 | $973 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $501 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $351 |
| Lilly USA, LLC | 10 | $177 |
| QOL Medical, LLC | 9 | $143 |
| Pfizer | 1 | $134 |
| Blueprint Medicines Corporation | 1 | $119 |
| Cumberland Pharmaceuticals, Inc. | 5 | $83 |
| Ardelyx, Inc. | 4 | $82 |
| Celltrion USA Inc. | 5 | $79 |
| Merck | 5 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| UCB, Inc. | 2 | $23 |
| Sanofi | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| CSL Behring | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$5,695
- XELJANZ$134
How this compares
$8,643 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Parsippany
- Aryeh ShanderEnglewood$762K
- Ronak DesaiCamden$343K
- Joseph StaufferSkillman$95K
- Baher YanniEast Windsor$82K
- Adam ThalerBerkeley Heights$63K
- Elizabeth RocheWoodcliff Lake$45K
- William LeeSomerset$39K
- Jonathan JaffeMount Holly$36K
- Yitzhak BelshBerkeley Heights$29K
- Enrique PantinNew Brunswick$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.